Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren

Tranexamsäure (topisch) – Forschungsarchiv – Seite 13 von 15 | SupStack

Tranexamsäure (topisch) – Forschungsarchiv

Studien 1551–1600 von 1669, neueste zuerst

Die 1000 neuesten Studien – mit Evidenz-Zusammenfassung, Filtern und Suche – stehen auf der Hauptseite. Dieses Archiv listet die übrigen, 50 pro Seite. Zurück zur Hauptseite

1551RCT2003

Krohn CD, Sørensen R, Lange JE, Riise R, Bjørnsen S, Brosstad F · Eur J Surg Suppl (2003)

Für dieses Zitat ist keine Zusammenfassung hinterlegt — öffne die Arbeit, um das Abstract zu lesen.

1552RCT2003

Carter G, Goss A · Int J Oral Maxillofac Surg (2003)

Für dieses Zitat ist keine Zusammenfassung hinterlegt — öffne die Arbeit, um das Abstract zu lesen.

1553RCT2002

Dowd NP, Karski JM, Cheng DC, Carroll JA, Lin Y, James RL · Anesthesiology (2002)

Für dieses Zitat ist keine Zusammenfassung hinterlegt — öffne die Arbeit, um das Abstract zu lesen.

Tranexamsäure (topisch) – Forschungsarchiv

Tranexamic acid given into the wound reduces postoperative blood loss by half in major orthopaedic surgery.

Tranexamic acid mouthwash--a prospective randomized study of a 2-day regimen vs 5-day regimen to prevent postoperative bleeding in anticoagulated patients requiring dental extractions.

Pharmacokinetics of tranexamic acid during cardiopulmonary bypass.

Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study.

Hemostatic effects of tranexamic acid in elective thoracic aortic surgery: a prospective, randomized, double-blind, placebo-controlled study.

Tranexamic acid reduces bleeding and the need for blood transfusion in primary myocardial revascularization.

Tranexamic acid as a means of reducing the need for blood and blood component therapy in children undergoing open heart surgery for congenital cyanotic heart disease.

Tranexamic acid given intraoperatively reduces blood loss after total knee replacement: a randomized, controlled study.

Does tranexamic acid reduce desmopressin-induced hyperfibrinolysis?

Tranexamic acid in patients with hemoptysis.

Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points.

A comparative study of the postoperative allogeneic blood-sparing effects of tranexamic acid and of desmopressin after total knee replacement.

Tranexamic acid administration after cardiac surgery: a prospective, randomized, double-blind, placebo-controlled study.

Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.

The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement.

A randomized trial of tranexamic acid to reduce blood transfusion for scoliosis surgery.

Regional hemostatic status and blood requirements after total knee arthroplasty with and without tranexamic acid or aprotinin.

Tranexamic acid in aortic valve replacement.

Effect of tranexamic acid on blood loss reduction after cardiopulmonary bypass.

Influence of Helicobacter pylori infection and cetraxate on gastric mucosal blood flow during healing of endoscopic mucosal resection-induced ulcers.

[Clinical study on the efficacy of tranexamic acid in reducing postpartum blood lose: a randomized, comparative, multicenter trial].

Tranexamic acid in off-pump coronary surgery: a preliminary, randomized, double-blind, placebo-controlled study.

Tranexamic acid reduces blood loss in total hip replacement surgery.

[The effect of aprotinin and tranexamic acid on fibrinolysis and thrombin generation during cardiopulmonary bypass].

Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation.

Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR Study Group.

Postoperative bleeding after coronary revascularization. Comparison between tranexamic acid and epsilon-aminocaproic acid.

Cetraxate, a mucosal protective agent, combined with omeprazole, amoxycillin, and clarithromycin increases the eradication rate of helicobacter pylori in smokers.

Aprotinin and tranexamic acid for high transfusion risk cardiac surgery.

Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty.

Topical use of tranexamic acid in coronary artery bypass operations: a double-blind, prospective, randomized, placebo-controlled study.

Comparison of blood-conservation strategies in cardiac surgery patients at high risk for bleeding.

Hemostatic parameters and platelet activation marker expression in cyanotic and acyanotic pediatric patients undergoing cardiac surgery in the presence of tranexamic acid.

Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.

Antifibrinolytic therapy with tranexamic acid in cardiac operations.

A comparative study of the postoperative allogeneic blood-sparing effect of tranexamic acid versus acute normovolemic hemodilution after total knee replacement.

The effect of tranexamic acid (cyclokapron) on blood loss after third molar extraction under a day case general anaesthetic.

Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty.

Reduction of blood loss and transfusion requirements after coronary artery bypass grafting: similar efficacy of tranexamic acid and aprotinin in aspirin-treated patients.

Comparative study of antifibrinolytic drugs in orthotopic liver transplantation.

Comparison of tranexamic acid and prednisolone in the treatment of traumatic hyphema. A randomized clinical trial.

The association of tranexamic acid and nimodipine in the pre-operative treatment of ruptured intracranial aneurysms.

Prophylactic tranexamic acid and epsilon-aminocaproic acid for primary myocardial revascularization.

The effectiveness of low dose tranexamic acid in primary cardiac surgery.

Tranexamic acid and aprotinin reduce postoperative bleeding and transfusions during primary coronary revascularization.

The effect of three different doses of tranexamic acid on blood loss after cardiac surgery with mild systemic hypothermia (32 degrees C).

Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty.

The effect of tranexamic acid on local and plasma fibrinolysis during total knee arthroplasty.

Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass operations: a double-blind, randomized, placebo-controlled trial.

Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery.